SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > Free Zone > Penny Trading - Technical > BB''s Stock Haven

$GRPOF Tetra Bio-Pharma files patent for treatment of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Campeese Member Profile
 
Followed By 24
Posts 2,086
Boards Moderated 0
Alias Born 10/31/16
160x600 placeholder
Campeese   Friday, 05/19/17 12:21:04 PM
Re: None
Post # of 4166982 
$GRPOF Tetra Bio-Pharma files patent for treatment of cancer, ocular disease


Tetra Bio-Pharma Inc. (CSE: C.TBP, OTCQB: GRPOF, Forum) said Thursday it has submitted a provisional patent application with the U.S. patent and trademark office for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease.

The global market for cancer drugs has hit US$100 billion in annual sales, and could reach US$147 billion by 2018, according to a new report by IMS Institute for Healthcare Informatics.


The Ontario-based company was in the news recently when it and and Aphria Inc. (TSX: V.APH, OTCQB: APHQF, Forum) announced plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

Tetra and Aphria will enter into a joint supply agreement, the companies said in a press release.
Read more at http://www.stockhouse.com/news/newswire/2017/05/18/tetra-bio-pharma-files-patent-for-treatment-cancer-ocular-disease#v5bq4J20Y5Hzv1ck.99


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist